The US Food and Drug Administration (FDA) on Friday authorized the emergency use of Moderna and Pfizer-BioNTech’s COVID-19 vaccines for children as young as 6 months of age, asserting that the ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
With an FDA expansion for GSK’s respiratory syncytial virus vaccine, Arexvy, for at-risk adults ages 18 to 49, the British company has caught up with Pfizer and Moderna, which scored nods for the age ...
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push into obesity drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results